Researchers have found that length of time between cancer diagnosis and treatment initiation may affect survival in certain settings, particularly for patients with early-stage breast cancer, lung cancer, and pancreatic cancer. Furthermore, treatment initiation can lead to greater anxiety, decreased satisfaction with care, and overall poorer quality of life for patients.
Currently, the goal of England’s National Health Service is to treat all patients within approximately 2 months of diagnosis (though this target is frequently not met). In the United States, large academic treatment centers have a median time to treatment initiation of about 6 weeks. Read more . . .